StandardStandard

Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia. / Chapman, Elinor A; Oates, Melanie; Mohammad, Ishaque S et al.
Yn: Oncotarget, Cyfrol 8, Rhif 61, 28.11.2017, t. 102948-102964.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Chapman, EA, Oates, M, Mohammad, IS, Davies, BR, Stockman, PK, Zhuang, J & Pettitt, AR 2017, 'Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia', Oncotarget, cyfrol. 8, rhif 61, tt. 102948-102964. https://doi.org/10.18632/oncotarget.22292

APA

Chapman, E. A., Oates, M., Mohammad, I. S., Davies, B. R., Stockman, P. K., Zhuang, J., & Pettitt, A. R. (2017). Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia. Oncotarget, 8(61), 102948-102964. https://doi.org/10.18632/oncotarget.22292

CBE

MLA

VancouverVancouver

Chapman EA, Oates M, Mohammad IS, Davies BR, Stockman PK, Zhuang J et al. Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia. Oncotarget. 2017 Tach 28;8(61):102948-102964. doi: 10.18632/oncotarget.22292

Author

Chapman, Elinor A ; Oates, Melanie ; Mohammad, Ishaque S et al. / Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia. Yn: Oncotarget. 2017 ; Cyfrol 8, Rhif 61. tt. 102948-102964.

RIS

TY - JOUR

T1 - Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia

AU - Chapman, Elinor A

AU - Oates, Melanie

AU - Mohammad, Ishaque S

AU - Davies, Barry R

AU - Stockman, Paul K

AU - Zhuang, Jianguo

AU - Pettitt, Andrew R

PY - 2017/11/28

Y1 - 2017/11/28

N2 - The functional significance of AKT in chronic lymphocytic leukemia (CLL) remains unclear. Given the importance of non-malignant T cells in regulating clonal expansion in CLL, we investigated the role of AKT in T cell-mediated cytoprotection and proliferation using an established co-culture system in which primary CLL cells were incubated on a monolayer of transfected mouse fibroblasts expressing human CD40L (CD154). Stimulation of CLL cells via CD40 induced activation of AKT, which was closely associated with downregulation of its negative regulator PTEN, and protected CLL cells from killing by bendamustine. This cytoprotective effect of CD40 stimulation was prevented by a selective inhibitor of AKT. Stimulation of CLL cells with CD154 + IL-4 or IL-21 induced proliferation detected as reduced fluorescence of cells pre-stained with CFSE. AKT inhibition produced a significant, consistent reduction in proliferation induced by CD154 + IL-4 and a reduction in proliferation induced by CD154 + IL-21 in most but not all cases. In contrast, AKT inhibition had no effect on the proliferation of normal B cells induced by CD154 + IL-4 or IL-21. These findings indicate that AKT contributes in a significant way to T-cell mediated survival and proliferation signalling in CLL and support the clinical evaluation of AKT inhibitors in this disease.

AB - The functional significance of AKT in chronic lymphocytic leukemia (CLL) remains unclear. Given the importance of non-malignant T cells in regulating clonal expansion in CLL, we investigated the role of AKT in T cell-mediated cytoprotection and proliferation using an established co-culture system in which primary CLL cells were incubated on a monolayer of transfected mouse fibroblasts expressing human CD40L (CD154). Stimulation of CLL cells via CD40 induced activation of AKT, which was closely associated with downregulation of its negative regulator PTEN, and protected CLL cells from killing by bendamustine. This cytoprotective effect of CD40 stimulation was prevented by a selective inhibitor of AKT. Stimulation of CLL cells with CD154 + IL-4 or IL-21 induced proliferation detected as reduced fluorescence of cells pre-stained with CFSE. AKT inhibition produced a significant, consistent reduction in proliferation induced by CD154 + IL-4 and a reduction in proliferation induced by CD154 + IL-21 in most but not all cases. In contrast, AKT inhibition had no effect on the proliferation of normal B cells induced by CD154 + IL-4 or IL-21. These findings indicate that AKT contributes in a significant way to T-cell mediated survival and proliferation signalling in CLL and support the clinical evaluation of AKT inhibitors in this disease.

U2 - 10.18632/oncotarget.22292

DO - 10.18632/oncotarget.22292

M3 - Article

C2 - 29262536

VL - 8

SP - 102948

EP - 102964

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 61

ER -